CN Stock MarketDetailed Quotes

300142 Walvax Biotechnology

Watchlist
  • 10.14
  • -0.13-1.27%
Market Closed Sep 6 15:00 CST
16.22BMarket Cap120.71P/E (TTM)

Walvax Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-33.88%1.43B
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
51.27%655.89M
Operating revenue
-33.88%1.43B
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
51.27%655.89M
Other operating revenue
314.92%13.71M
----
3.51%7.92M
----
-40.96%3.3M
----
-27.15%7.65M
----
8.83%5.6M
----
Total operating cost
-22.77%1.18B
-30.14%462.15M
-17.18%3.15B
-15.59%2.32B
-9.79%1.53B
27.85%661.54M
44.85%3.81B
76.83%2.75B
72.20%1.69B
62.05%517.42M
Operating cost
5.20%286.73M
-9.07%113.52M
-1.95%597.56M
3.88%451.26M
-6.92%272.57M
64.36%124.85M
54.55%609.47M
60.86%434.39M
76.23%292.83M
39.37%75.96M
Operating tax surcharges
-52.60%9.34M
-64.08%4.17M
-3.68%32.03M
1.09%25.37M
50.32%19.71M
134.35%11.62M
67.71%33.25M
96.91%25.1M
60.98%13.11M
53.10%4.96M
Operating expense
-36.12%500.22M
-31.01%210.46M
-24.85%1.52B
-22.78%1.14B
-13.33%783.05M
18.70%305.03M
51.93%2.02B
94.64%1.48B
80.97%903.5M
63.57%256.98M
Administration expense
1.88%123.17M
6.10%61.79M
9.65%297.62M
-2.72%180.63M
6.17%120.9M
6.59%58.23M
-9.44%271.42M
-8.10%185.68M
-17.15%113.87M
-9.89%54.63M
Financial expense
21.26%-27.77M
13.44%-14.8M
-12.72%-70.99M
1.10%-53.19M
-10.75%-35.26M
-20.32%-17.1M
-62.65%-62.98M
-105.73%-53.78M
-98.79%-31.84M
-83.26%-14.21M
-Interest expense (Financial expense)
133.17%6.35M
164.41%3.38M
-16.30%5.95M
-31.83%3.76M
-26.11%2.72M
-57.67%1.28M
23.15%7.11M
38.49%5.51M
58.42%3.69M
211.10%3.02M
-Interest Income (Financial expense)
8.69%-33.11M
-3.64%-18.31M
-6.01%-74.23M
-2.19%-52.66M
-5.98%-36.26M
-3.47%-17.67M
-54.19%-70.03M
-70.35%-51.53M
-83.52%-34.21M
-92.61%-17.08M
Research and development
-21.42%286.96M
-51.36%87.02M
-16.77%776.43M
-15.34%573.44M
-8.77%365.19M
28.61%178.91M
50.11%932.89M
101.94%677.34M
113.50%400.31M
169.71%139.11M
Credit Impairment Loss
196.73%58.69M
-1,402.83%-9.89M
-92.81%-88.52M
-186,850.31%-67.08M
-1,587.95%-60.68M
-254.44%-658.31K
-216.11%-45.91M
99.76%-35.88K
575.49%4.08M
-91.08%426.26K
Asset Impairment Loss
-1,774.78%-67.34M
-8.55%-7.61M
-164.60%-162.64M
57.44%-12.57M
71.30%-3.59M
-870.11%-7.01M
-418.91%-61.47M
-423.77%-29.54M
-19.10%-12.51M
78.89%-722.31K
Other net revenue
-599.75%-66.28M
-282.35%-77.95M
-92.27%-347.59M
54.69%-57.86M
76.38%-9.47M
193.47%42.75M
-44.72%-180.78M
-1,086.84%-127.72M
-140.44%-40.1M
-135.75%-45.74M
Fair value change income
-477.86%-102.01M
-7,010.23%-84.82M
-17.77%-234.75M
68.31%-67.39M
75.39%-17.65M
98.52%-1.19M
29.00%-199.33M
-125.78%-212.64M
-511.82%-71.73M
-181.58%-80.36M
Invest income
-42.25%3.65M
132.44%86.84K
-39.69%7.11M
30.18%6.29M
1,266.22%6.33M
-76.86%-267.7K
-79.62%11.8M
-91.68%4.84M
-100.93%-542.64K
72.95%-151.36K
-Including: Investment income associates
100.32%1.31K
140.26%86.84K
135.58%382.09K
34.76%-437.76K
25.55%-404.02K
-42.50%-215.69K
-15.18%-1.07M
7.70%-670.98K
-38.60%-542.64K
72.95%-151.36K
Asset deal income
-162.80%-108.16K
----
-116.55%-827.73K
-1,703.04%-574.86K
--172.21K
--172.21K
-265.55%-382.24K
-116.58%-31.88K
----
----
Other revenue
-38.08%40.83M
-53.05%24.28M
15.30%132.03M
-23.91%83.46M
62.40%65.95M
47.44%51.7M
63.55%114.51M
141.19%109.69M
23.01%40.61M
330.53%35.07M
Operating profit
-70.19%188.42M
-72.19%59.65M
-44.16%613.97M
-6.00%779.31M
2.58%632.06M
131.30%214.48M
54.79%1.1B
47.10%829.07M
32.11%616.16M
-2.27%92.73M
Add:Non operating Income
13,799.10%126.92M
-99.79%101.88
619.41%935.06K
1,413.66%933.18K
1,242.62%913.18K
231.12%48.85K
-95.02%129.98K
-97.13%61.65K
-96.78%68.02K
-99.16%14.75K
Less:Non operating expense
661.34%37.65M
-36.87%2.4M
-45.28%15.92M
-74.18%6.02M
-70.10%4.94M
-58.74%3.8M
638.26%29.1M
694.08%23.33M
452.91%16.54M
318.56%9.2M
Total profit
-55.78%277.69M
-72.83%57.25M
-44.05%598.98M
-3.92%774.22M
4.72%628.02M
152.24%210.73M
50.99%1.07B
43.17%805.8M
28.82%599.7M
-11.54%83.54M
Less:Income tax cost
-69.18%20.18M
52.41%18.94M
-33.72%87.65M
-34.25%76.99M
-32.99%65.47M
-26.00%12.43M
22.91%132.24M
49.40%117.1M
68.46%97.7M
-1.66%16.79M
Net profit
-54.22%257.52M
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
Net profit from continuing operation
-54.22%257.52M
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
Less:Minority Profit
-18.97%86.96M
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
-37.78%28.13M
Net profit of parent company owners
-62.53%170.56M
-91.79%14.13M
-42.44%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
70.35%728.65M
45.84%531.39M
31.90%421.01M
20.09%38.62M
Earning per share
Basic earning per share
-62.52%0.1066
-91.81%0.0088
-42.34%0.2621
2.40%0.3458
8.18%0.2844
345.64%0.1074
66.70%0.4546
44.69%0.3377
28.37%0.2629
16.43%0.0241
Diluted earning per share
-62.52%0.1066
-91.81%0.0088
-42.32%0.2621
2.49%0.3458
8.38%0.2844
345.64%0.1074
67.12%0.4544
45.62%0.3374
30.16%0.2624
16.99%0.0241
Other composite income
-96.66%850K
Other composite income of parent company owners
----
----
----
----
----
----
-96.66%850K
----
----
----
Total composite income
-54.22%257.52M
-80.68%38.31M
-45.55%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
49.82%939.08M
42.16%688.7M
23.17%501.99M
-13.72%66.75M
Total composite income of parent company owners
-62.53%170.56M
-91.79%14.13M
-42.51%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
60.97%729.5M
45.84%531.39M
31.90%421.01M
20.09%38.62M
Total composite income of minority owners
-18.97%86.96M
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
-37.78%28.13M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -33.88%1.43B-28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B51.27%655.89M
Operating revenue -33.88%1.43B-28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B51.27%655.89M
Other operating revenue 314.92%13.71M----3.51%7.92M-----40.96%3.3M-----27.15%7.65M----8.83%5.6M----
Total operating cost -22.77%1.18B-30.14%462.15M-17.18%3.15B-15.59%2.32B-9.79%1.53B27.85%661.54M44.85%3.81B76.83%2.75B72.20%1.69B62.05%517.42M
Operating cost 5.20%286.73M-9.07%113.52M-1.95%597.56M3.88%451.26M-6.92%272.57M64.36%124.85M54.55%609.47M60.86%434.39M76.23%292.83M39.37%75.96M
Operating tax surcharges -52.60%9.34M-64.08%4.17M-3.68%32.03M1.09%25.37M50.32%19.71M134.35%11.62M67.71%33.25M96.91%25.1M60.98%13.11M53.10%4.96M
Operating expense -36.12%500.22M-31.01%210.46M-24.85%1.52B-22.78%1.14B-13.33%783.05M18.70%305.03M51.93%2.02B94.64%1.48B80.97%903.5M63.57%256.98M
Administration expense 1.88%123.17M6.10%61.79M9.65%297.62M-2.72%180.63M6.17%120.9M6.59%58.23M-9.44%271.42M-8.10%185.68M-17.15%113.87M-9.89%54.63M
Financial expense 21.26%-27.77M13.44%-14.8M-12.72%-70.99M1.10%-53.19M-10.75%-35.26M-20.32%-17.1M-62.65%-62.98M-105.73%-53.78M-98.79%-31.84M-83.26%-14.21M
-Interest expense (Financial expense) 133.17%6.35M164.41%3.38M-16.30%5.95M-31.83%3.76M-26.11%2.72M-57.67%1.28M23.15%7.11M38.49%5.51M58.42%3.69M211.10%3.02M
-Interest Income (Financial expense) 8.69%-33.11M-3.64%-18.31M-6.01%-74.23M-2.19%-52.66M-5.98%-36.26M-3.47%-17.67M-54.19%-70.03M-70.35%-51.53M-83.52%-34.21M-92.61%-17.08M
Research and development -21.42%286.96M-51.36%87.02M-16.77%776.43M-15.34%573.44M-8.77%365.19M28.61%178.91M50.11%932.89M101.94%677.34M113.50%400.31M169.71%139.11M
Credit Impairment Loss 196.73%58.69M-1,402.83%-9.89M-92.81%-88.52M-186,850.31%-67.08M-1,587.95%-60.68M-254.44%-658.31K-216.11%-45.91M99.76%-35.88K575.49%4.08M-91.08%426.26K
Asset Impairment Loss -1,774.78%-67.34M-8.55%-7.61M-164.60%-162.64M57.44%-12.57M71.30%-3.59M-870.11%-7.01M-418.91%-61.47M-423.77%-29.54M-19.10%-12.51M78.89%-722.31K
Other net revenue -599.75%-66.28M-282.35%-77.95M-92.27%-347.59M54.69%-57.86M76.38%-9.47M193.47%42.75M-44.72%-180.78M-1,086.84%-127.72M-140.44%-40.1M-135.75%-45.74M
Fair value change income -477.86%-102.01M-7,010.23%-84.82M-17.77%-234.75M68.31%-67.39M75.39%-17.65M98.52%-1.19M29.00%-199.33M-125.78%-212.64M-511.82%-71.73M-181.58%-80.36M
Invest income -42.25%3.65M132.44%86.84K-39.69%7.11M30.18%6.29M1,266.22%6.33M-76.86%-267.7K-79.62%11.8M-91.68%4.84M-100.93%-542.64K72.95%-151.36K
-Including: Investment income associates 100.32%1.31K140.26%86.84K135.58%382.09K34.76%-437.76K25.55%-404.02K-42.50%-215.69K-15.18%-1.07M7.70%-670.98K-38.60%-542.64K72.95%-151.36K
Asset deal income -162.80%-108.16K-----116.55%-827.73K-1,703.04%-574.86K--172.21K--172.21K-265.55%-382.24K-116.58%-31.88K--------
Other revenue -38.08%40.83M-53.05%24.28M15.30%132.03M-23.91%83.46M62.40%65.95M47.44%51.7M63.55%114.51M141.19%109.69M23.01%40.61M330.53%35.07M
Operating profit -70.19%188.42M-72.19%59.65M-44.16%613.97M-6.00%779.31M2.58%632.06M131.30%214.48M54.79%1.1B47.10%829.07M32.11%616.16M-2.27%92.73M
Add:Non operating Income 13,799.10%126.92M-99.79%101.88619.41%935.06K1,413.66%933.18K1,242.62%913.18K231.12%48.85K-95.02%129.98K-97.13%61.65K-96.78%68.02K-99.16%14.75K
Less:Non operating expense 661.34%37.65M-36.87%2.4M-45.28%15.92M-74.18%6.02M-70.10%4.94M-58.74%3.8M638.26%29.1M694.08%23.33M452.91%16.54M318.56%9.2M
Total profit -55.78%277.69M-72.83%57.25M-44.05%598.98M-3.92%774.22M4.72%628.02M152.24%210.73M50.99%1.07B43.17%805.8M28.82%599.7M-11.54%83.54M
Less:Income tax cost -69.18%20.18M52.41%18.94M-33.72%87.65M-34.25%76.99M-32.99%65.47M-26.00%12.43M22.91%132.24M49.40%117.1M68.46%97.7M-1.66%16.79M
Net profit -54.22%257.52M-80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M-13.72%66.75M
Net profit from continuing operation -54.22%257.52M-80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M-13.72%66.75M
Less:Minority Profit -18.97%86.96M-8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M-37.78%28.13M
Net profit of parent company owners -62.53%170.56M-91.79%14.13M-42.44%419.39M4.14%553.38M8.13%455.24M345.34%171.99M70.35%728.65M45.84%531.39M31.90%421.01M20.09%38.62M
Earning per share
Basic earning per share -62.52%0.1066-91.81%0.0088-42.34%0.26212.40%0.34588.18%0.2844345.64%0.107466.70%0.454644.69%0.337728.37%0.262916.43%0.0241
Diluted earning per share -62.52%0.1066-91.81%0.0088-42.32%0.26212.49%0.34588.38%0.2844345.64%0.107467.12%0.454445.62%0.337430.16%0.262416.99%0.0241
Other composite income -96.66%850K
Other composite income of parent company owners -------------------------96.66%850K------------
Total composite income -54.22%257.52M-80.68%38.31M-45.55%511.33M1.24%697.23M12.06%562.55M197.09%198.3M49.82%939.08M42.16%688.7M23.17%501.99M-13.72%66.75M
Total composite income of parent company owners -62.53%170.56M-91.79%14.13M-42.51%419.39M4.14%553.38M8.13%455.24M345.34%171.99M60.97%729.5M45.84%531.39M31.90%421.01M20.09%38.62M
Total composite income of minority owners -18.97%86.96M-8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M-37.78%28.13M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg